Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Menhycia in Children 4-6 Years Old
NCT06011200Phase 3Completed
- Sponsor
- CanSino Biologics Inc.
- Start
- Sep 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil + finasteride in meningococcal meningitis, sponsored by CanSino Biologics Inc.. Started Sep 2023; status: completed.
02
Drugs
minoxidil + finasteride
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT06011200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06011200.